亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費(fèi)注冊|忘記密碼|管理入口 返回主站||保存桌面|手機(jī)瀏覽|聯(lián)系方式|購物車
企業(yè)會員第1年

岳陽市嘉誠生物科技有限公司銷售部  

高效氯氟氰菊酯,匹可硫酸鈉,溴蟲睛,3,4,5一三甲氧基肉桂酸,2,4一二羥基苯甲酸,三乙脂,烯丙基硫脲

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
  • 聯(lián)系人:熊先生
  • 電話:0730-8705981
  • 郵件:gcns08@ycgmp.com
  • 傳真:0730-8705981
  • QQ:2355779402
站內(nèi)搜索
 
榮譽(yù)資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
醋酸生育酚
單價 面議對比
詢價 暫無
發(fā)貨 湖南岳陽市付款后3天內(nèi)
品牌 南箭
過期 長期有效
更新 2019-06-27 09:08
 
詳細(xì)信息
 醋酸生育酚
D-alpha-生育酚醋酸酯
中文同義詞:[2R-[2R*(4R*,8R*)]]-3,4-二氫-2,5,7,8-四甲基-2-(4,8,12-三甲基三癸基)-2H-1-苯并呋喃-6-酚乙酸酯;維生素E乙酸酯;乙酸維生素E;D-VE 維生素E-醋酸酯;[2R-[2R*(4R*;8R*)]]-3,4-二氫-2,5,7,8-四甲基-2-(4,8,12-三甲基三癸基)-2H-1-苯并呋喃-6-酚乙酸酯;醋酸生育酚;維他命E醋酸鹽
英文名稱:D-alpha-Tocopheryl acetate
英文同義詞:VITAMIN E ACETATE (D-FORM);VITAMIN E ALPHA TOCOPHEROL ACETATE;VITAMINE E-ACETATE;(2r,4’r,8’r)-alpha-tocopherylacetate;(2R,4’R,8’R)-O-Acetyl-α-tocopherol;(r,r,r)-alpha-tocopherylacetate;[2R-[2R*(4R8,8R*)]]-3,4-Dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-ol acetate;2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-,acetate,(+)-6-chromano
CAS號: 58-95-7
分子式: C31H52O3
分子量: 472.74
 
用途:生化研究;臨床藥物屬脂溶性維生素,臨床用于習(xí)慣性流產(chǎn)、先兆性流產(chǎn)、不孕癥及更年期障礙等癥的治療。
©2025 岳陽市嘉誠生物科技有限公司銷售部 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:12074  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |